Octogenarian liver grafts: Is their use for transplant currently justified?

Table 2 Recipient characteristics n (%)

Characteristics	Donors ≤ 65 years	Donors ≥ 80 years	P value
	Group A (n = 102)	Group B (n = 51)
Mean recipient age (yr)	52.6 ± 11.5	58.0 ± 8.7	0.044
Sex (male/female)	71/31	42/9	0.091
BMI	27.3 ± 4.0	27.3 ± 4.7	0.400
Etiology
Alcoholic cirrhosis	47 (46.1)	29 (56.9)	0.200
Viral C cirrhosis	16 (15.7)	10 (19.6)	0.540
Viral B cirrhosis	9 (8.8)	5 (9.8)	0.840
Hepatocarcinoma	24 (23.5)	18 (36.0)	0.100
Other	29 (28.4)	9 (17.6)	0.140
Child-Pugh distribution:			0.310
Grade A	19 (18.7)	13 (25.5)
Grade B	40 (39.2)	24 (47.0)
Grade C	43 (42.1)	14 (27.5)
MELD score	14.9 ± 5.5	14.5 ± 6.5	0.570
D-MELD score	706 ± 400	1205 ± 526	0.220
UNOS status:			0.160
Home	91 (89.2)	50 (98.1)
Hospital	9 (8.8)	1 (1.9)
ICU	2 (2.0)	0 (0)
Antecedents:
Diabetes	16 (15.7)	13 (25.5)	0.140
High blood pressure	19 (18.6)	13 (25.5)	0.320
Cardiopathy	20 (19.6)	12 (23.5)	0.570
Renal disease	8 (7.8)	3 (5.9)	0.650
Pre-LT laboratory values
Hemoglobin (g/100 mL)	11.5 ± 2.120	11.8 ± 2.3	0.300
Leukocytes/mm3	5264 ± 2060	5249 ± 2757	0.330
Platelets/mm3	97376 ± 55284	95568 ± 51651	0.910
Total bilirubin (mg/dL)	4.5 ± 7.5	2.7 ± 3.9	0.130
GOT (IU/L)	70 ± 59	74 ± 89	0.220
GPT (IU/L)	45 ± 36	51 ± 71	0.100
GGT (IU/L)	129 ± 159	100 ± 123	0.220
Alkaline phosphatase (IU/L)	233 ± 240	169 ± 129	0.067
Prothrombin rate (%)	63 ± 19	67 ± 21	0.650
Serum albumin (g/L)	3.36 ± 0.63	3.38 ± 0.64	0.570
Serum creatinine (mg/dL)	0.97 ± 0.42	1.07 ± 0.58	0.660
Serum glucose (mg/dL)	115 ± 47	143 ± 80	< 0.001

LT: Liver transplantation; ICU: Intensive care unit; GOT: Glutamic oxaloacetic transaminase; GPT: Glutamic pyruvic transaminase; GGT: γ-glutamyl transpeptidase.